Escalon Medical Corp. (OTCMKTS:ESMC) Short Interest Update

Escalon Medical Corp. (OTCMKTS:ESMC) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 100 shares, a decrease of 98.2% from the February 29th total of 5,700 shares. Based on an average daily volume of 15,500 shares, the short-interest ratio is presently 0.0 days.

Escalon Medical Stock Performance

OTCMKTS ESMC remained flat at $0.21 during trading hours on Thursday. The company had a trading volume of 3,127 shares, compared to its average volume of 4,573. The company has a market cap of $1.56 million, a PE ratio of 5.25 and a beta of -0.54. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.09 and a current ratio of 1.64. The business’s 50 day simple moving average is $0.21 and its two-hundred day simple moving average is $0.24. Escalon Medical has a 1-year low of $0.07 and a 1-year high of $0.39.

Escalon Medical (OTCMKTS:ESMC) last posted its earnings results on Wednesday, February 14th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $2.87 million for the quarter. Escalon Medical had a return on equity of 39.40% and a net margin of 3.85%.

About Escalon Medical

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.